Now that we are a little more than 3 months into the trial, has anyone seen or heard anything from any patients, relating to whether or not 113 is working, or it's side effects?
The only information that I have found is that quite a few NSCLC patients have been talking about trying to get into the trial and that their oncologists have discussed 113 with them.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.